REAL-WORLD EXPERIENCE OF USING TOFACITINIB IN ULCERATIVE COLITIS IN BIOLOGIC NAIVE AND BIOLOGIC EXPOSED PATIENTS

被引:0
|
作者
Cheesbrough, Jonathan [1 ]
Sharma, Naveen [1 ]
Nassar, Islam [1 ]
Quraishi, Nabil [1 ]
机构
[1] Univ Hosp Birmingham, Birmingham, W Midlands, England
关键词
D O I
10.1136/gutjnl-2022-BSG.76
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P14
引用
收藏
页码:A42 / A42
页数:1
相关论文
共 50 条
  • [1] Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naive and biologic exposed patients
    Cheesbrough, J.
    Quraishi, M. N.
    Sharma, N.
    Nassar, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I444
  • [2] Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naive and biologic exposed patients
    Cheesbrough, J.
    Quraishi, M. N.
    Sharma, N.
    Nassar, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I444
  • [3] Letter: tofacitinib in biologic-experienced ulcerative colitis-a single-centre real-world experience in Australia
    Lo, S. W.
    Connell, W.
    Kamm, M. A.
    Lust, M.
    Wright, E. K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 532 - 533
  • [4] TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY
    Cremer, Anneline
    Lobaton, Triana
    Vieujean, Sophie
    Bossuyt, Peter
    Rahier, Jean-Francois
    Baert, Filip J.
    Dewit, Olivier
    Macken, Elisabeth
    Somers, Michael
    Vijverman, Anne
    Van Hootegem, Philippe
    Mana, Fazia
    Willandt, Barbara
    Caenepeel, Philip
    Humblet, Evelien
    D'Heygere, Francois
    Verreth, Annelies
    El Nawar, Abdo
    Coenegrachts, Jean-Louis
    Dewit, Sophie
    De Coninck, Steven
    Schoofs, Nele
    Delen, Stefan
    Dutre, Joris
    Thienpont, Clara
    Vanden Branden, Stijn
    Staessen, Dirk
    Franchimont, Denis
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1208 - S1208
  • [5] Real-world experience of tofacitinib in Australia for treatment of ulcerative colitis
    Khoo, E.
    Lee, A.
    Lo, S. W.
    Wright, E.
    Ghaly, S.
    Makanyanga, J.
    Thin, L.
    Fang, W.
    Niewiadomski, O.
    Chung, A.
    Digby-Bell, J.
    Sparrow, M.
    Shelton, E.
    Jakobovits, S.
    Scott, D.
    Ward, M.
    Ardalan, Z. S. M.
    An, Y-K
    Begun, J.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 124 - 125
  • [6] TOFACITINIB IN ULCERATIVE COLITIS: EARLY REAL-WORLD EXPERIENCE IN SOUTHAMPTON
    Young, David
    Ventress, Esther
    Harris, Richard
    McDonnell, Martin
    Bettey, Marion
    Gwiggner, Markus
    Felwick, Richard
    Smith, Trevor
    Cummings, Fraser
    [J]. GUT, 2021, 70 : A130 - A130
  • [7] A real-world study of outcomes in biologic-naive patients with Crohn's disease and ulcerative colitis initiating vedolizumab
    Raluy, M.
    Alam, N.
    Donaldson, R.
    Smyth, M.
    Khalid, J. M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S238 - S238
  • [8] Efficacy and safety of tofacitinib for the treatment of moderate- severe ulcerative colitis in biologic naive patients
    Liatsos, C.
    Michalopoulos, G.
    Tzouvala, M.
    Giouleme, O.
    Kozompoli, D.
    Mousourakis, K.
    Kyriakos, N.
    Giakoumis, M.
    Striki, A.
    Karoumpalis, I.
    Bellou, G.
    Zacharopoulou, E.
    Katsoula, A.
    Kalogirou, M.
    Viazis, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1718 - I1718
  • [9] Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
    Deepak, Parakkal
    Alayo, Quazim A.
    Khatiwada, Aava
    Lin, Bixuan
    Fenster, Marc
    Dimopoulos, Christina
    Bader, Geoffrey
    Weisshof, Roni
    Jacobs, Michael
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    Christophi, George P.
    Patel, Anish
    Hirten, Robert P.
    Colombel, Jean-Frederic
    Rubin, David T.
    Ha, Christina
    Beniwal-Patel, Poonam
    Ungaro, Ryan C.
    Syal, Gaurav
    Pekow, Joel
    Cohen, Benjamin L.
    Yarur, Andres
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1592 - +
  • [10] EARLY USE OF VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH ULCERATIVE COLITIS: A REAL-WORLD ANALYSIS OF HEALTHCARE UTILIZATION
    Patel, Haridarshan
    Khalid, Javaria M.
    Shah, Surbhi
    Shah, Rikisha
    Berger, Ariel
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S371 - S371